Misdiagnosis of type 1 diabetes in adults and of monogenic diabetes at all ages often occurs, with adverse consequences.

The FDA’s approval of linvoseltamab for adults with heavily pretreated relapsed/refractory multiple myeloma marks a significant advance, with Sundar Jagannath, MBBS, emphasizing its high response ...